Comparative Pharmacokinetics and Insulin Action for Three Rapid-Acting Insulin Analogs Injected Subcutaneously With and Without Hyaluronidase

Comparative Pharmacokinetics and Insulin Action for Three Rapid-Acting Insulin Analogs Injected Subcutaneously With and Without Hyaluronidase

Bibliographic Details
Main Authors:	Morrow, Linda, Muchmore, Douglas B., Hompesch, Marcus, Ludington, Elizabeth A., Vaughn, Daniel E.
Format:	Online
Language:	English
Published:	American Diabetes Association 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554283/

Similar Items

Haemorrhagic shock induced by subcutaneous insulin injection
by: Kimura, Tomonori, et al.
Published: (2011)

Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency
by: Jolles, Stephen
Published: (2013)

Pharmacokinetics and pharmacodynamics of insulin analogs in special populations with type 2 diabetes mellitus
by: Morello, Candis M
Published: (2011)

Efficacy and safety of switching to insulin glulisine from other rapid-acting insulin analogs in children with type 1 diabetes
by: Urakami, Tatsuhiko, et al.
Published: (2015)

Improved Pharmacokinetic and Pharmacodynamic Profile of Rapid-Acting Insulin Using Needle-Free Jet Injection Technology
by: Engwerda, Elsemiek E.C., et al.
Published: (2011)

Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects
by: de la Peña, Amparo, et al.
Published: (2011)

Clinical Immunogenicity of rHuPH20, a Hyaluronidase Enabling Subcutaneous Drug Administration
by: Rosengren, Sanna, et al.
Published: (2015)

Glargine and detemir: Safety and efficacy profiles of the long-acting basal insulin analogs
by: Poon, Kitty, et al.
Published: (2010)

Insulin Analogs and Cancer
by: Sciacca, Laura, et al.
Published: (2012)

Diabetic Ketosis Caused by the Insulin Analog Aspart–Induced Anti-Insulin Antibody: Successful Treatment With the Newest Insulin Analog Glulisine
by: Yanai, Hidekatsu, et al.
Published: (2011)

Generating local amyloidosis in mice by the subcutaneous injection of human insulin amyloid fibrils
by: CHINISAZ, MARYAM, et al.
Published: (2014)

Glucose-Lowering Effect of Insulin Degludec is Independent of Subcutaneous Injection Region
by: Nosek, Leszek, et al.
Published: (2014)

Treatment of Type 1 and Type 2 Diabetes Mellitus with Insulin Detemir, a Long-Acting Insulin Analog
by: Young, Jason R., et al.
Published: (2010)

Evaluation of skin and subcutaneous tissue thickness at insulin injection sites in Indian, insulin naïve, type-2 diabetic adult population
by: Jain, Sunil M., et al.
Published: (2013)

Towards a Physiological Prandial Insulin Profile: Enhancement of Subcutaneously Injected Prandial Insulin Using Local Warming Devices
by: El-Laboudi, Ahmed H., et al.
Published: (2015)

Biosimilar insulins: guidance for data interpretation by clinicians and users
by: Heinemann, L., et al.
Published: (2015)

Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase
by: Shpilberg, O, et al.
Published: (2013)

Faster‐acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart
by: Heise, T., et al.
Published: (2015)

The Additional Effect of Hyaluronidase in Lumbar Interlaminar Epidural Injection
by: Kim, Sang Beom, et al.
Published: (2011)

In vitro inhibition of hyaluronidase by sodium copper chlorophyllin complex and chlorophyllin analogs
by: McCook, John P, et al.
Published: (2015)

Hyperinsulinemic hypoglycemia associated with insulin antibodies caused by exogenous insulin analog
by: Su, Chih-Ting, et al.
Published: (2016)

Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetes
by: Bolli, G B, et al.
Published: (2011)

Protein acts as "sensor" for insulin
Published: (2002)

Pharmacokinetics of olanzapine long-acting injection: the clinical perspective
by: Heres, Stephan, et al.
Published: (2014)

Comparison of continuous subcutaneous insulin infusion and insulin glargine-based multiple daily insulin aspart injections with preferential adjustment of basal insulin in patients with type 2 diabetes
by: GAO, GUAN-QI, et al.
Published: (2014)

Role of Subcutaneous Adipose Tissue in the Pathogenesis of Insulin Resistance
by: Patel, Pavankumar, et al.
Published: (2013)

Continuous subcutaneous insulin infusion: practical issues
by: Saboo, Banshi D., et al.
Published: (2012)

A Continuous Subcutaneous Insulin Infusion Needle Break
by: George, Minu M., et al.
Published: (2015)

Real world outcomes of adding rapid-acting insulin versus switching to analog premix insulin among US patients with type 2 diabetes treated with insulin glargine
by: Miao, Raymond, et al.
Published: (2013)

Insulin Analogs—Is There a Compelling Case to Use Them? No!
by: Davidson, Mayer B.
Published: (2014)

Insulin Analogs and Cancer: A Note of Caution
by: Janssen, Joseph A. M. J. L., et al.
Published: (2014)

Modern basal insulin analogs: An incomplete story
by: Singh, Awadhesh Kumar, et al.
Published: (2014)

The Effect of DPT-1 Intravenous Insulin Infusion and Daily Subcutaneous Insulin on Endogenous Insulin Secretion and Postprandial Glucose Tolerance
by: Hao, Wei, et al.
Published: (2015)

Changes in Glycemic Control and Quality of Life in Pediatric Type 1 Diabetics with Continuous Subcutaneous Insulin Infusion of Insulin Aspart Following Multiple Daily Injection Therapy
by: Kawamura, Tomoyuki, et al.
Published: (2008)

Prolonged hyperinsulinemia after subcutaneous injection of 2400 U regular insulin in a suicide attempt: Time course of serum insulin with frequent measurements
by: Hiromine, Yoshihisa, et al.
Published: (2012)

Insulin Degludec: A Significant Advancement in Ultralong-Acting Basal Insulin
by: Kalra, Sanjay
Published: (2013)

Proinsulin-Transferrin Fusion Protein as a Novel Long-Acting Insulin Analog for the Inhibition of Hepatic Glucose Production
by: Wang, Yan, et al.
Published: (2014)

The Effect of Hyaluronidase in Interlaminar Lumbar Epidural Injection for Failed Back Surgery Syndrome
by: Kim, Sang Beom, et al.
Published: (2012)

Hyaluronidase injection for the treatment of eyelid edema: a retrospective analysis of 20 patients
by: Hilton, Said, et al.
Published: (2014)

Effects of Subacromial Bursa Injection With Corticosteroid and Hyaluronidase According to Dosage
by: Choi, Won Duck, et al.
Published: (2013)